Cardiol Therapeutics Inc. CRDL.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 44.28% | -52.44% | 28.49% | -19.81% | -4.56% |
| Total Depreciation and Amortization | -57.44% | 4.84% | 0.00% | 1.09% | 5.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -71.28% | 23.70% | -29.57% | 17.55% | 155.65% |
| Change in Net Operating Assets | 546.66% | 119.19% | -0.15% | -193.10% | 558.60% |
| Cash from Operations | 42.27% | -46.21% | 25.45% | -52.87% | 34.02% |
| Capital Expenditure | 93.66% | -1,477.27% | 0.00% | 53.19% | 43.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 93.66% | -1,477.27% | 0.00% | 53.19% | 43.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -83.23% | -7.41% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -159.20% | -- | -- | -- |
| Cash from Financing | -81.95% | -11.10% | 110,515.84% | -168.24% | 254.17% |
| Foreign Exchange rate Adjustments | 39.80% | 143.01% | -240.32% | 166.12% | -439.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.22% | -35.08% | 247.22% | -29.52% | 27.44% |